Mirtazapine Tablet, Film Coated
Product Images NDC 70518-2581

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 70518-2581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Label for Mirtazapine 45 mg film coated tablets, oral use, containing 30 tablets. The label includes the NDC number 70518-2581-00 and states the product is Rx only. Manufactured by Rising Pharma, Inc., Allendale, NJ, and repackaged by RemedyRepack Inc., Indiana, PA. Directions refer to the package insert, with storage instructions at 20-25°C. Contains safety warning to keep medication out of reach of children.*
FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical Structure (Mirtazapine Str)
Chemical structure of mirtazapine, a human prescription drug active ingredient, showing its molecular ring system and chemical bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.